Published in Can J Infect Dis on March 01, 1994
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics (1977) 4.64
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med (1991) 2.48
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J (1991) 2.47
Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA (1992) 2.40
Protection from infection with Haemophilus influenzae type b by monoclonal antibody to the capsule. J Infect Dis (1982) 1.57
Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J (1987) 1.53
Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr (1992) 1.38
Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis (1990) 1.35
Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. J Pediatr (1988) 1.30
Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. Pediatrics (1987) 1.11
Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J Infect Dis (1992) 1.09
Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b. J Infect Dis (1990) 1.00
Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J Pediatr (1992) 0.99
Haemophilus influenzae meningitis in Manitoba and the Keewatin District, NWT: potential for mass vaccination. CMAJ (1988) 0.96
Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. Pediatrics (1990) 0.89
Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia. J Infect Dis (1993) 0.82
Advisory Committee on Immunization Practices update: report of PedvaxHIB lots with questionable immunogenicity. MMWR Morb Mortal Wkly Rep (1992) 0.80
Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide--Neisseria meningitidis outer membrane protein. Vaccine (1991) 0.78
Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet (1998) 5.22
The role of secondary vaccine failures in measles outbreaks. Am J Public Health (1989) 2.10
New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology (2006) 2.02
Hypertensive encephalopathy: antecedent to hippocampal sclerosis and temporal lobe epilepsy? Neurology (2003) 1.51
New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva. J Clin Microbiol (1997) 1.21
Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun (1987) 1.20
Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. J Pediatr (1997) 1.10
Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet (1997) 1.10
Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods (1992) 1.09
Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Am J Public Health (1998) 1.08
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J (1994) 1.07
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
A new categorization of HLA DR alleles on a functional basis. Hum Immunol (1998) 1.03
Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s. Toxicol Appl Pharmacol (2000) 1.00
Identification of the sex-determining locus of Atlantic salmon (Salmo salar) on chromosome 2. Cytogenet Genome Res (2006) 0.97
Kinetics of expulsion of the nematode, Nippostrongylus brasiliensis, in mast-cell deficient W/WV mice. Parasite Immunol (1983) 0.96
Delta toxin activity in coagulase-negative staphylococci from the bowels of neonates. J Clin Microbiol (1988) 0.96
Structural abnormalities remote from the seizure focus: a study using T2 relaxometry at 3 T. Neurology (2004) 0.96
Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays. J Clin Microbiol (1992) 0.95
Genetic control of immunity to Trichinella spiralis in mice. Response of rapid- and slow-responder strains to immunization with parasite antigens. Parasite Immunol (1986) 0.95
Amino acid sequence of a deltalike toxin from Staphylococcus epidermidis. Infect Immun (1990) 0.94
Arterial spin-labeled perfusion of pediatric brain tumors. AJNR Am J Neuroradiol (2013) 0.92
Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense. Immunology (1986) 0.92
Lipomatous meningioma: characteristic computed tomographic appearance. Australas Radiol (1996) 0.90
Cystic meningioangiomatosis in neurofibromatosis type 2: an MRI-pathological study. Br J Radiol (2009) 0.90
Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome. J Immunol (1993) 0.89
A swimming pool-associated outbreak of Cryptosporidiosis in British Columbia. Can J Public Health (1994) 0.89
Case report: CT and MRI of the cauda equina syndrome in ankylosing spondylitis. Clin Radiol (1992) 0.89
Giardiasis outbreak from a chlorinated community water supply. Can J Public Health (1991) 0.88
Thermodilution and Fick cardiac index determinations following cardiac surgery. Crit Care Med (1976) 0.87
Characterization of an overlapping CD8+ and CD4+ T-cell epitope on rubella capsid protein. Virology (1997) 0.86
Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica (2000) 0.86
Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2007) 0.86
Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype. Hum Immunol (1998) 0.85
Differential IgG avidity to rubella virus structural proteins. J Med Virol (1992) 0.85
Genetic influences upon eosinophilia and resistance in mice infected with Trichinella spiralis. Parasitology (1992) 0.84
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Defining mechanisms of toxicity for linoleic acid monoepoxides and diols in Sf-21 cells. Chem Res Toxicol (2001) 0.83
Occurrence of hippocampal sclerosis: is one hemisphere or gender more vulnerable? Epilepsia (1999) 0.83
Reduction of rubella ELISA background using heat denatured sample buffer. J Immunol Methods (1991) 0.83
Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis. Clin Exp Immunol (1989) 0.83
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine (1995) 0.83
Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia. J Infect Dis (1993) 0.82
Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus. Diabetologia (2000) 0.82
HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. J Rheumatol (1997) 0.82
Survey of bereaved parents. CMAJ (1986) 0.82
Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition. Hum Immunol (1994) 0.82
A simple simulation for the visualisation of CSF flow in infants with hydrocephalus. Ultrasound Med Biol (1994) 0.81
Sequential follow up observations of a patient with rubella associated persistent arthritis. Ann Rheum Dis (1992) 0.81
Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia. Can Dis Wkly Rep (1989) 0.80
Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein. Vaccine (1997) 0.80
Antibody responses induced by immunization of inbred mice susceptible and resistant to African trypanosomes. Infect Immun (1983) 0.80
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J (1999) 0.80
Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions. Eur J Immunol (1996) 0.80
Antibody responses in resistant and susceptible inbred mice infected with Trypanosoma congolense. Immunology (1986) 0.80
Near-total absence of the cerebellum. Neuropediatrics (2001) 0.80
Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine (1996) 0.79
Breastfeeding and antibody responses to routine vaccination in infants. Lancet (1992) 0.79
Evaluation of ready-to-use and multi-dose influenza vaccine formats in large clinic settings. Can J Public Health (2000) 0.78
Genetic control of eosinophilia in parasitic infections: responses of mouse strains to treatment with cyclophosphamide and parasite antigen. Int J Parasitol (1988) 0.77
Experience with diffusion-weighted imaging in an acute stroke unit. Cerebrovasc Dis (1998) 0.77
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old. Scand J Infect Dis (1995) 0.77
Adoptive transfer of enhanced eosinophilia and resistance to infection in mice by an in vitro generated T-cell line specific for Mesocestoides corti larval antigen. Parasite Immunol (1987) 0.77
Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine. Vaccine (1997) 0.76
Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines. J Pediatr (1999) 0.76
What do parents learn by reading a DPT vaccine information form? Can J Infect Dis (1994) 0.75
Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology (2000) 0.75
Genetic influences upon eosinophilia and resistance in mice infected with Mesocestoides corti. Parasitology (1990) 0.75
Cancer plasma effects on skeletal muscle metabolism. Curr Surg (1989) 0.75
Is Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) compatible with diphtheria-pertussis-tetanus vaccine in young infants? Pediatr Infect Dis J (1993) 0.75
Pulmonary effects of ventilatory pattern following cardiopulmonary bypass. Crit Care Med (1990) 0.75
Characterization of the HLA-restrictive elements of a rubella virus-specific cytotoxic T cell clone: influence of HLA-DR4 beta chain residue 74 polymorphism on antigenic peptide-T cell interaction. Int Immunol (1996) 0.75
Linoleic acid prevents chloride influx and cellular lysis in rabbit renal proximal tubules exposed to mitochondrial toxicants. Toxicol Appl Pharmacol (2001) 0.75
Critical requirements in regional health planning. Can J Public Health (1975) 0.75
Public health and environmental planning--the Cariboo experience. Can J Public Health (1972) 0.75
Measles outbreak in a Vancouver school population: relative risk and vaccine efficacy. Can J Public Health (1988) 0.75
Extrapulmonary influences on A-aD021.0 following cardiopulmonary bypass. Anesthesiology (1975) 0.75
Future of the MOH. Can J Public Health (1979) 0.75
Predicting total weight of retail-ready lamb cuts from bioelectrical impedance measurements taken at the processing plant. J Anim Sci (1994) 0.75
A comparative study of PENTA vaccine booster doses given at 12, 15, or 18 months of age. Vaccine (1999) 0.75
Point mutation of a rubella virus E1 protein T-cell epitope by substitution of single amino acid reversed the restrictive HLA-DR polymorphism: a possible mechanism maintaining HLA polymorphism. Viral Immunol (1998) 0.75